24 certified Labor Condition Applications on file with the U.S. Department of Labor, FY2021–FY2026.
Since September 2025, DOL's Project Firewall opens H-1B investigations without waiting for a complaint. These checkpoints come from Janssen Scientific Affairs, LLC's own public LCA filings (FY2024–FY2026) — the same records an investigator pulls first.
Each worksite needs its own 10-business-day LCA notice and a PAF record of that posting; a move to a new area of intended employment needs a new LCA before the worker starts there.
Level I is the entry-level prevailing-wage tier and the band DOL's Project Firewall reviews first for misclassification (senior duties filed at an entry-level wage). The national share is 17%.
Median offered wage is 24% above the DOL prevailing wage across 12 recent certified LCAs. Paying at the floor is lawful, but it invites the question of whether the wage level itself is right.
No additional recruitment or non-displacement attestations apply.
Public DOL disclosure data can lag actual filings by a quarter. Descriptive only — not legal advice.
Yes — Janssen Scientific Affairs, LLC sponsors H-1B workers, with 24 certified LCAs on file (FY2021–FY2026), including 5 in FY2026. The median certified salary is $180,000 (P25 $168,900, P75 $197,150). With a 44% transfer share, this employer actively accepts H-1B transfers. 100% of its certified filings meet or exceed the prevailing wage.
Janssen Scientific Affairs, LLC H-1B sponsorship at a glance, from public U.S. DOL LCA disclosure data (FY2021–FY2026).
Certified LCAs are a prerequisite to H-1B petitions, not visa approvals; one LCA can cover multiple workers. Descriptive only — not legal advice.
The shaded band is the middle half of certified salaries (P25–P75); the bar spans the lowest to highest certified salary.
Levels I–IV are DOL prevailing-wage experience tiers; 87% of filings are senior-level (III–IV).
| Fiscal year | Certified | Denied | Withdrawn | Total |
|---|---|---|---|---|
| FY2021 | 4 | 2 | 0 | 6 |
| FY2022 | 6 | 0 | 0 | 6 |
| FY2023 | 2 | 0 | 0 | 2 |
| FY2024 | 2 | 0 | 0 | 2 |
| FY2025 | 5 | 0 | 0 | 5 |
| FY2026 | 5 | 0 | 0 | 5 |
Case dispositions from the U.S. DOL OFLC disclosure files. Withdrawn are LCAs that were certified and later withdrawn by the employer; they still count toward Total.
| Job title | Salary | Level | Location | Filed | Status |
|---|---|---|---|---|---|
Director Real World Value and EOH I-200-26160-995650 | $255,200/yr | IV | Horsham, PA | Jun 09, 2026 | Certified |
Associate Director, Real World Value and Evidence–Hematology I-200-26104-790723 | $185,000/yr | IV | Horsham, PA | Apr 14, 2026 | Certified |
Principal Scientific Account Lead I-200-25365-519367 | $137,000/yr | IV | Exton, PA | Dec 31, 2025 | Certified |
Associate Director, Real World Value and Evidence - Oncology I-200-25309-376835 | $195,000/yr | III | Livingston, NJ | Nov 05, 2025 | Certified |
Senior Medical Science Liaison (MSL) I-200-25307-364404 | $200,000/yr | IV | Kenmore, WA | Nov 03, 2025 | Certified |
Associate Director, RWVE Oncology I-200-25183-148440 | $182,800/yr | IV | Horsham, PA | Jul 02, 2025 | Certified |
Manager, Search Solutions I-200-25162-081810 | $183,600/yr | IV | Titusville, NJ | Jun 11, 2025 | Certified |
Associate Director, Real World Value and Evidence, Oncology I-200-25134-975553 | $200,650/yr | IV | Horsham, PA | May 14, 2025 | Certified |
Principal Scientific Account Lead I-200-25134-975513 | $190,000/yr | IV | Titusville, NJ | May 14, 2025 | Certified |
Manager, Real World Value & Evidence, Oncology I-200-24324-484366 | $168,900/yr | III | Horsham, PA | Nov 19, 2024 | Certified |
Manager, Real World Value & Evidence, Oncology I-200-24095-855635 | $168,900/yr | IV | Horsham, PA | Apr 04, 2024 | Certified |
Integrated Evidence Team Leader, Aticaprant I-203-23362-597147 | $233,400/yr | IV | Titusville, NJ | Dec 28, 2023 | Certified |
Director, Real World Value & Evidence, Oncology I-200-23130-010979 | $220,000/yr | IV | Horsham, PA | May 10, 2023 | Certified |
Associate Director, Real World Value & Evidence, Oncology I-200-23111-956250 | $196,200/yr | IV | Horsham, PA | Apr 21, 2023 | Certified |
Associate Director STRAT COMMS AND LEARNING ONC SOLID I-200-22256-468807 | $150,000/yr | IV | Titusville, NJ | Sep 13, 2022 | Certified |
Associate Director- Real World Value & Evidence - Oncology I-200-22112-098762 | $175,000/yr | IV | Horsham, PA | Apr 22, 2022 | Certified |
Medical Director of Pipeline and Innovation - Mood I-203-22066-956818 | $225,000/yr | IV | Titusville, NJ | Mar 07, 2022 | Certified |
Manager, Real World Value & Evidence, Oncology I-200-21278-624382 | $155,000/yr | III | Sterling, VA | Oct 05, 2021 | Certified |
Manager, Market Access Analytics I-200-21277-622059 | $145,000/yr | II | Titusville, NJ | Oct 04, 2021 | Certified |
Manager, Real World Value & Evidence, Oncology I-200-21273-617586 | $155,000/yr | IV | Horsham, PA | Sep 30, 2021 | Certified |
Associate Director, Real World Value & Evidence, Immunology I-200-21166-400144 | $175,000/yr | IV | Horsham, PA | Jun 15, 2021 | Certified |
Manager Real World Research I-200-21039-061505 | $130,000/yr | II | Titusville, NJ | Feb 08, 2021 | Denied |
Associate Director, Real World Value & Evidence, Oncology I-200-20281-863959 | $180,000/yr | II | Horsham, PA | Oct 07, 2020 | Certified |
One row per LCA case (its latest version), from U.S. DOL OFLC disclosure data. Salaries are the offered wage, converted to a yearly figure. Certified LCAs are not visa approvals.
Worker positions by LCA filing purpose, summed across FY2021–FY2026 disclosure records.
Most active filing months: Apr and Oct — useful for timing transfer conversations.
Attestations from the employer's own LCA filings (Form ETA-9035), as disclosed by the U.S. DOL.
4 states · 6 cities
The same DOL data on this page is what every H-1B sponsor must track for each worker. ElevateStaffing.ai automates it end-to-end:
Get the private PAF / LCA gap check for your own filings — free, one business day — then let ElevateStaffing.ai keep every LCA, PAF, I-9 and I-983 deadline audit-ready.
Get my private gap check →